AbbVie Inc (4AB.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
At close: 08:21PM CEST
| Previous Close | 152.12 |
| Open | 152.32 |
| Bid | 152.62 x 0 |
| Ask | 153.66 x 0 |
| Day's Range | 152.32 - 153.32 |
| 52 Week Range | 119.00 - 168.52 |
| Volume | |
| Avg. Volume | 2 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Key Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to their trading...
- Zacks
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
AbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult patients with relapsed/refractory follicular lymphoma after two or more prior therapies.
© 2024 Yahoo. All rights reserved.